IQ-AI boosted with second FDA rare pediatric disease designa

IQ-AI boosted with second FDA rare pediatric disease designation for GaM

IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) told investors that its subsidiary, Imaging Biometrics, has received a second US FDA Rare Pediatric Disease Designation...

Related Keywords

, Trevor Brown , World Health Organization , Imaging Biometrics , Pediatric Disease Designation , Priority Review Vouchers , Rare Pediatric Disease Designation , Health Organization ,

© 2025 Vimarsana